108 related articles for article (PubMed ID: 4404082)
1. Absence of potentiation of phenylephrine-induced cardiac necroses by theophylline. Selective inhibition by dihydroergocryptine and nicergoline.
Bellini O; Glässer AH
J Pharm Pharmacol; 1972 Sep; 24(9):741-2. PubMed ID: 4404082
[No Abstract] [Full Text] [Related]
2. [Clinical study on treatment with nicergoline in a group of patients with hemiplegia in a post-acute phase].
Zucconi V; Bolaffio MT
Minerva Med; 1974 Mar; 65(17):936-45. PubMed ID: 4151126
[No Abstract] [Full Text] [Related]
3. [Preliminary study on the effect of a nicergoline composition (F.I. 6714) on cerebral blood flow].
Prencipe M; Cecconi V; Pisarri F
Farmaco Prat; 1974 May; 29(5):278-84. PubMed ID: 4152517
[No Abstract] [Full Text] [Related]
4. [Clinical pharmacology of adrenergic agonists and antagonists. I. Alpha-adrenergic agonists and antagonists].
Hugues FC; Baillet J; Sardal J; Marche J
Coeur Med Interne; 1972; 11(4):749-55. PubMed ID: 4405691
[No Abstract] [Full Text] [Related]
5. Estimation of changes induced by drugs in cerebral energy-coupling processes in situ in the dog.
Benzi G; Arrigoni E; Manzo L; De Bernardi M; Ferrara A; Panceri P; Berte F
J Pharm Sci; 1973 May; 62(5):758-64. PubMed ID: 4145186
[No Abstract] [Full Text] [Related]
6. Quantitative evaluation of release and reuptake of adrenergic transmitter in the rabbit heart.
Wennmalm A
Acta Physiol Scand; 1971 Aug; 82(4):532-8. PubMed ID: 4398620
[No Abstract] [Full Text] [Related]
7. 10-Methoxyergoline derivatives as -adrenergic blocking agents.
Arcari G; Bernardi L; Bosisio G; Coda S; Fregnan GB; Glässer AH
Experientia; 1972 Jul; 28(7):819-20. PubMed ID: 4144586
[No Abstract] [Full Text] [Related]
8. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
Loew DM; Jaton AL; Vigouret JM
Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
[No Abstract] [Full Text] [Related]
9. The role of cyclic AMP in isoprenaline-induced cardiac necroses in the rat.
Martorana PA
J Pharm Pharmacol; 1971 Mar; 23(3):200-3. PubMed ID: 4396891
[No Abstract] [Full Text] [Related]
10. [Influence of nicergoline on the cerebral blood flow and alpha-sympatholytical properties (author's transl)].
Lievre M; Ollagnier M; Faucon G
Arzneimittelforschung; 1979; 29(8a):1227-31. PubMed ID: 44198
[TBL] [Abstract][Full Text] [Related]
11. Influence of an alpha-1-adrenoceptor antagonist, nicergoline, on placental prostanoid production in streptozotocin-induced diabetic pregnant rats.
Chartrel N; Clabaut M; Boismare F; Schrub JC
Biol Neonate; 1990; 57(3-4):218-23. PubMed ID: 1969751
[TBL] [Abstract][Full Text] [Related]
12. [Conservative treatment of cerebral insufficiency. Experiences with wallerox].
Poser G
Munch Med Wochenschr; 1971 May; 113(19):738-41. PubMed ID: 4995708
[No Abstract] [Full Text] [Related]
13. [Evidence for an alpha 2-blocking property of nicergoline by using antilipolytic alpha-adrenoceptors from adipose tissue].
Carpéné C; Lafontan M; Berlan M
J Pharmacol; 1983; 14(1):57-66. PubMed ID: 6132024
[TBL] [Abstract][Full Text] [Related]
14. [Role of adrenergic mechanisms in pharmacological actions on the cerebral circulation].
Mirzoian RS
Vestn Akad Med Nauk SSSR; 1973; 28(12):14-7. PubMed ID: 4150722
[No Abstract] [Full Text] [Related]
15. [Clinical trials on the suspension of ovulation in women by the use of anti-sympathotonic substances of the ergotamine group, as well as by other substances of the chlorpromazine and meprobamate type].
Giarola A; Agostini G; Campanelli D
Gynecol Prat; 1970; 21(5):397-402. PubMed ID: 4995898
[TBL] [Abstract][Full Text] [Related]
16. Effect of dihydroergotamine on plasma free fatty acids (FFA) in dogs.
Scriabine A; Bellet S; Kershbaum A; Feinberg LJ
Life Sci; 1968 May; 7(9):453-63. PubMed ID: 4967825
[No Abstract] [Full Text] [Related]
17. [Pharmacodynamics of the cerebral circulation. Angiographic study].
Cappellini M; De Marzi S
Nunt Radiol; 1967 Nov; 33(11):1343-62. PubMed ID: 4977950
[No Abstract] [Full Text] [Related]
18. Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol.
Boismare F; Moore N; Decourt S; Paux G; Saligaut C; Chretien P
Methods Find Exp Clin Pharmacol; 1983; 5(2):83-8. PubMed ID: 6876944
[TBL] [Abstract][Full Text] [Related]
19. [Vasoactive drugs and cerebral circulation].
Pratesi F; Corsi C; Tesi M; Spinelli P; Brunetti S; Caramelli L
Minerva Med; 1968 Dec; 59(96):5207-17. PubMed ID: 4974813
[No Abstract] [Full Text] [Related]
20. Effect of nimergoline (F.I. 6714) on human platelet aggregation in vitro.
Praga C; Pogliani E
Acta Med Scand Suppl; 1971; 525():263-6. PubMed ID: 5292099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
